1 / 29

Russell Vang, MD, and Brigitte M. Ronnett, MD

Distinction of Primary Ovarian Mucinous Tumors and Mucinous Tumors Metastatic to the Ovary A Practical Approach With Guidelines for Prediction of Primary Site for Metastases of Uncertain Origin. Russell Vang, MD, and Brigitte M. Ronnett, MD

sirvat
Download Presentation

Russell Vang, MD, and Brigitte M. Ronnett, MD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Distinction of Primary Ovarian Mucinous Tumors and Mucinous Tumors Metastatic to the OvaryA Practical Approach With Guidelines for Prediction of Primary Site for Metastases of Uncertain Origin Russell Vang, MD, and Brigitte M. Ronnett, MD Pathology Case Reviews • Volume 11, Number 1, January/February 2006

  2. CASE PRESENTATION • 33y/o, female • A right ovarian cyst • No history of cervical diseases • laparoscopic salpingo-oophorectomy • spongy and papillary tissue measuring 12.5 cm in aggregate

  3. FIGURE 1 • FIGURE 1.variably sized cysts lined by stratified and tufted mucinous epithelium separated by ovarian stroma as well as areas having confluent glandular growth.

  4. FIGURE 2.atypical, hyperchromatic nuclei with numerous mitotic figures and apoptotic bodies and intraglandular cribriform growth

  5. →→Primary ovarian atypical proliferative (borderline) mucinous tumor with intraepithelial carcinoma. • P16:+, HPV 16: + • Endocervical and endometrial curettages: dendocervical adenoCA • →→→Metastatic endocervical adenocarcinoma

  6. GENERAL FEATURES OF METASTASESINVOLVING THE OVARIES • 8% of malignant ovarian neoplasms • From nongynecologic sites are 11 times more common ( esp. GI tract ) • Characteristic gross features • Smaller size (often less than 10 cm) • Bilateral involvement • Nodular growth pattern • Presence of tumor on the surface and/or in the superficial cortex of the ovary. • Solid and compress the surrounding ovarian stroma.

  7. Characteristic microscopic features • Infiltrative growth pattern with stromal desmoplasia • Nodular growth pattern with involvement of the ovarian surface and superficial cortex • Hilar and lymphvascular space involvement.

  8. PATHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES OF PRIMARY OVARIAN MUCINOUS TUMORS • Atypical Proliferative (Borderline) Mucinous Tumors of Gastrointestinal Type and Mucinous Carcinomas • Stage I unilateral • 19 to 20 cm • Internal surfaces are generally smooth • Intraepithelium • CK7:+, CK:20:variable, always negetive • Dpc4:+, CEA:+, ER、PR、CA125：+/-

  9. （GI type）Intraglandular epithelial proliferation but lacks glandular confluence or infiltrative growth (a). diffuse expression of CK7 (b) patchy expression of CK20 (c).

  10. (Gastrointestinal) type. glandular/cribriform growth pattern.

  11. Teratoma: Negative for CK7 (c) and diffusely positive for CK20 (d).

  12. Colorectal Adenocarcinomas • Unilateral*** • 11 to 15 cm • Cystic or solid. Hemorrhage and necrosis • Endometrioid-like appearance • Abundant extracellular mucin (colloid carcinoma) or signet ring cell differentiation. • “Garland pattern” of “dirty necrosis” • CK7：-, CK20：+, Dpc4：+ • Rectum, right side, high grade: more CK7

  13. Nodular growth pattern (a), glands infiltrating within a desmoplastic stroma (b), or display a “garland pattern” with “dirty necrosis” (c). Other tumors simulate primary ovarian mucinous tumors when they exhibit confluent glandular (d) or villoglandular (e) growth patterns lacking infiltrative growth.

  14. CK7：-(f) • CK20：+ (g) • Occasionally, a colorectal adenocarcinoma can simulate a primary ovarian mucinous tumor (h) • Patchy expression of CK7 (i) combined with diffuse expression of CK20 (j) distinguishes these colorectal tumors from primary ovarian tumors

  15. PancreaticobiliaryAdenocarcinomas • Bilateral • 7-13cm • Multiloculated mucinous cystic masses • Compress surrounding ovarian stroma • CK7：+, CK20：variable • Dpc4 lost: pancreas→50%, the others→34% • CA125：+/-

  16. Glands haphazardly infiltrating a desmoplastic stroma (a) and surface/superficial cortical involvement by a nodular plaque of carcinoma (b); however, some carcinomas can grow in glandular (c) or villoglandular (d) patterns without stromal invasion, simulating an atypical proliferative (borderline) mucinous tumor of gastrointestinal type.

  17. Diffuse expression of CK7 (e) and focal/patchy expression of CK20 (f), similar to primary ovarian mucinous tumors. Approximately half of tumors show loss of expression of Dpc4 (g) [the background stroma serves as an internal positive control], which distinguishes them from primary ovarian mucinous tumors.

  18. Gastric Adenocarcinomas • Bilateral • Solid • Signet ring cell carcinoma, typically within a hypercellular ovarian stroma (“Krukenberg tumor”). • CK7>CK20, always • Dpc4:+

  19. signet ring cells within a hyper-cellular ovarian stroma (a). Not infrequently, the ovarian stroma contains ill-defined nodular hypercellular areas containing numerous signet ring cells juxtaposed with hypocellular edematous regions (b).

  20. Appendiceal Tumors (Secondary OvarianInvolvement by Low-Grade AdenomatousMucinous Neoplasms Associated WithPseudomyxoma Peritonei and MetastaticAdenocarcinomas) • Bilateral • Right side • Small than 10cm • Abundant dissecting extracellular mucin (pseudomyxoma ovarii) • Signet ring cells within a hypercellular stroma (“Krukenberg tumor”) • Adenocarcinoid type • CK7：-, typically, CK20：+, Dpc4:+

  21. intestinal-type glandular pattern (a), a goblet cell carcinoid/adenocarcinoid pattern (b), classic signet ring cell pattern (c).

  22. The tumor can simulate a primary ovarian mucinous tumor (a), but lack of expression of CK7 (b) combined with diffuse expression of CK20 (c) distinguishes these tumors from primary ovarian mucinous tumors.

  23. Endocervical Adenocarcinomas • Unilateral • mean size of 13 cm • ‘’usual type”→ HPV-related, glands exhibiting endometrioid and/or mucinous differentiation • Minimal deviation adenocarcinoma (adenoma malignum) unrelated to HPV, very welldifferentiated mucinous glands • CK7:+,CK20:-, Dpc4:+, P16,HPV:+(usual type)

  24. Confluent villoglandular patterns, simulating primary ovarian atypical proliferative mucinous tumors and well-differentiated carcinomas (a). The HPV-related type of endocervical adenocarcinoma is typically composed of epithelium exhibiting a hybrid of endometrioid and mucinous differentiation, composed of pseudostratified columnar cells with hyperchromatic elongated nuclei, numerous mitotic figures in the luminal half of the cell, and basal apoptotic bodies (arrows) (b).

  25. Diffuse strong expression of p16 (both nuclear and cytoplasmic) (c) is characteristic and is associated with the presence of high-risk HPV DNA, which can be detected by in situ hybridization (d).

  26. GUIDELINES FOR DISTINGUISHING PRIMARY OVARIAN MUCINOUS TUMORS FROM METASTATIC MUCINOUS TUMORS IN THE OVARY AND FOR PREDICTING PRIMARY SITE FOR METASTATIC CARCINOMAS OF UNKNOWN ORIGIN Intraoperative Consultation • Whether the patient has had any other documented tumors • Extraovarian disease, bilateral tumor, gross or microscopic nodularity, garland pattern necrosis, or signet ring cells→gastrointestinal tract • Mucinous ascites (pseudomyxoma peritonei) →evaluate and remove the appendix.

More Related